Cite
MLA Citation
Tae Hee Hong et al.. “Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purity.” Journal for immunotherapy of cancer, vol. 8, no. 2, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127572900.0x00002a